How Does Resistance to Nucleotide Biosynthesis Inhibitors Develop?
Resistance to inhibitors of nucleotide biosynthesis can develop through multiple mechanisms, such as mutations in the target enzymes that reduce drug binding, upregulation of compensatory pathways, and increased drug efflux. Understanding these resistance mechanisms is crucial for developing next-generation inhibitors and combination therapies.
